GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Teva Pharmaceutical Industries Ltd (MEX:TEVA N) » Definitions » Tariff Resilience Score

Teva Pharmaceutical Industries (MEX:TEVA N) Tariff Resilience Score : 6/10 (As of Jul. 13, 2025)


View and export this data going back to 2011. Start your Free Trial

What is Teva Pharmaceutical Industries Tariff Resilience Score?

Teva Pharmaceutical Industries has the Tariff Resilience Score of 6, which implies that the company might have Average Resilient.

Teva Pharmaceutical Industries has Teva has moderate exposure due to its global supply chain and manufacturing locations. It has faced past tariff impacts on raw materials but has strong pricing power and alternative suppliers. Industry-specific exemptions provide some relief.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Teva Pharmaceutical Industries might have Average Resilient.

Competitive Comparison of Teva Pharmaceutical Industries's Tariff Resilience Score

For the Drug Manufacturers - Specialty & Generic subindustry, Teva Pharmaceutical Industries's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Teva Pharmaceutical Industries's Tariff Resilience Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Teva Pharmaceutical Industries's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Teva Pharmaceutical Industries's Tariff Resilience Score falls into.


;
;

Teva Pharmaceutical Industries  (MEX:TEVA N) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Teva Pharmaceutical Industries Tariff Resilience Score Related Terms

Thank you for viewing the detailed overview of Teva Pharmaceutical Industries's Tariff Resilience Score provided by GuruFocus.com. Please click on the following links to see related term pages.

Teva Pharmaceutical Industries Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Teva Pharmaceutical Industries Ltd (MEX:TEVA N) » Definitions » Tariff Resilience Score
Comparable Companies
XTAE:KMDA XTAE:REKA XTAE:TKUN XTAE:NXTG XTAE:BLWV-M XTAE:CNTC ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ HKSE:03692 NSE:DIVISLAB SHSE:688506 TSE:4507 BOM:500087 SZSE:000538 NSE:TORNTPHARM
Traded in Other Exchanges
TEVJF:USA TEVA:USA TEVA:Israel 0LER:UK TEV:Germany TEV:Germany T1EV34:Brazil TEV:Bulgaria TEVA:Austria
Address
124 Dvora HaNevi’a Street, Tel Aviv, ISR, 6944020
Website
https://www.tevapharm.com
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

Teva Pharmaceutical Industries Headlines

No Headlines